Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "Thane"

37 News Found

Covestro to showcase material solutions from wound care to wearable smart patches
Medical Device | May 17, 2022

Covestro to showcase material solutions from wound care to wearable smart patches

Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis


Barentz acquires life science ingredients, specialty chemicals distributor Divsa
News | March 22, 2022

Barentz acquires life science ingredients, specialty chemicals distributor Divsa

Divsa's coverage across Central America bridges Barentz' leading positions in North and South America


IIFL AMC funds acquire stake in OmniActive Health Technologies
Startup | March 03, 2022

IIFL AMC funds acquire stake in OmniActive Health Technologies

OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation


Experts highlight positives of yoga in coping with Covid waves
Public Health | January 19, 2022

Experts highlight positives of yoga in coping with Covid waves

Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run


Wellness Forever Medicare expands its presence as it opens 15 new stores
Healthcare | August 18, 2021

Wellness Forever Medicare expands its presence as it opens 15 new stores

It strengthens its presence to over 250 stores


Low-cost flexible tactile sensors for robotics and biomedical applications developed
Drug Approval | August 12, 2021

Low-cost flexible tactile sensors for robotics and biomedical applications developed

The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery


Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities
News | April 05, 2021

Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities

ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E